{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:18:20Z","timestamp":1788459500485,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11102-026-01710-9","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:07:23Z","timestamp":1784815643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disentangling secretory ambiguity and the limitations of classical thresholds in defining prolactinomas"],"prefix":"10.1007","volume":"29","author":[{"given":"Maya","family":"Harary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishek","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart D.","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Donangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6423-5480","authenticated-orcid":false,"given":"Marvin","family":"Bergsneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"1710_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11102-014-0624-3","volume":"18","author":"O Cooper","year":"2015","unstructured":"Cooper O (2015) Silent corticotroph adenomas. Pituitary 18:225\u2013231. https:\/\/doi.org\/10.1007\/s11102-014-0624-3","journal-title":"Pituitary"},{"key":"1710_CR2","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3171\/2020.10.JNS203236","volume":"135","author":"BA Strickland","year":"2021","unstructured":"Strickland BA, Shahrestani S, Briggs RG et al (2021) Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence. J Neurosurg 135:1706\u20131713. https:\/\/doi.org\/10.3171\/2020.10.JNS203236","journal-title":"J Neurosurg"},{"key":"1710_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/00006254-198312000-00001","volume":"38","author":"R Sakiyama","year":"1983","unstructured":"Sakiyama R, Quan M (1983) Galactorrhea and hyperprolactinemia. Obstet Gynecol Surv 38:689\u2013700. https:\/\/doi.org\/10.1097\/00006254-198312000-00001","journal-title":"Obstet Gynecol Surv"},{"key":"1710_CR4","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol 19:722\u2013740. https:\/\/doi.org\/10.1038\/s41574-023-00886-5","journal-title":"Nat Rev Endocrinol"},{"key":"1710_CR5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/jama.2023.5444","volume":"329","author":"NA Tritos","year":"2023","unstructured":"Tritos NA, Miller KK (2023) Diagnosis and Management of Pituitary Adenomas: A Review. JAMA 329:1386. https:\/\/doi.org\/10.1001\/jama.2023.5444","journal-title":"JAMA"},{"key":"1710_CR6","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.3892\/ol.2017.7462","volume":"15","author":"Y Huang","year":"2018","unstructured":"Huang Y, Ding C, Zhang F et al (2018) Role of prolactin\/adenoma maximum diameter and prolactin\/adenoma volume in the differential diagnosis of prolactinomas and other types of pituitary adenomas. Oncol Lett 15:2010\u20132016. https:\/\/doi.org\/10.3892\/ol.2017.7462","journal-title":"Oncol Lett"},{"key":"1710_CR7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.eprac.2022.03.013","volume":"28","author":"A Faje","year":"2022","unstructured":"Faje A, Jones P, Swearingen B, Tritos NA (2022) The Prolactin per Unit Tumor Volume Ratio Accurately Distinguishes Prolactinomas From Secondary Hyperprolactinemia due to Stalk Effect. Endocr Pract 28:572\u2013577. https:\/\/doi.org\/10.1016\/j.eprac.2022.03.013","journal-title":"Endocr Pract"},{"key":"1710_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12020-021-02744-8","volume":"74","author":"K Wright","year":"2021","unstructured":"Wright K, Lee M, Escobar N et al (2021) Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas. Endocrine 74:138\u2013145. https:\/\/doi.org\/10.1007\/s12020-021-02744-8","journal-title":"Endocrine"},{"key":"1710_CR9","doi-asserted-by":"publisher","first-page":"901385","DOI":"10.3389\/fendo.2022.901385","volume":"13","author":"A Cho","year":"2022","unstructured":"Cho A, Vila G, Marik W et al (2022) Diagnostic criteria of small sellar lesions with hyperprolactinemia: Prolactinoma or else. Front Endocrinol (Lausanne) 13:901385. https:\/\/doi.org\/10.3389\/fendo.2022.901385","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1710_CR10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s11102-022-01246-8","volume":"25","author":"V Raverot","year":"2022","unstructured":"Raverot V, Perrin P, Chanson P et al (2022) Prolactin immunoassay: does the high-dose hook effect still exist? Pituitary 25:653\u2013657. https:\/\/doi.org\/10.1007\/s11102-022-01246-8","journal-title":"Pituitary"},{"key":"1710_CR11","doi-asserted-by":"publisher","first-page":"e488","DOI":"10.1016\/j.wneu.2021.12.074","volume":"159","author":"J-H Kim","year":"2022","unstructured":"Kim J-H, Hur K-Y, Hong S-D et al (2022) Serum Prolactin Level to Tumor Size Ratio as a Potential Parameter for Preoperative Differentiation of Prolactinomas from Hyperprolactinemia-Causing Non-functional Pituitary Adenomas. World Neurosurg 159:e488\u2013e496. https:\/\/doi.org\/10.1016\/j.wneu.2021.12.074","journal-title":"World Neurosurg"},{"key":"1710_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3171\/2019.3.JNS19121","volume":"133","author":"WT Burke","year":"2020","unstructured":"Burke WT, Penn DL, Castlen JP et al (2020) Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size. J Neurosurg 133:321\u2013328. https:\/\/doi.org\/10.3171\/2019.3.JNS19121","journal-title":"J Neurosurg"},{"key":"1710_CR13","doi-asserted-by":"publisher","first-page":"9801","DOI":"10.1038\/s41598-021-89256-7","volume":"11","author":"BM Leca","year":"2021","unstructured":"Leca BM, Mytilinaiou M, Tsoli M et al (2021) Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis. Sci Rep 11:9801. https:\/\/doi.org\/10.1038\/s41598-021-89256-7","journal-title":"Sci Rep"},{"key":"1710_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11060-025-05041-w","volume":"174","author":"C Mo","year":"2025","unstructured":"Mo C, Liu X, Guo Y et al (2025) Clinical characteristics and pathological features of growth hormone-secreting pituitary adenoma combined with hyperprolactinemia. J Neurooncol 174:131\u2013141. https:\/\/doi.org\/10.1007\/s11060-025-05041-w","journal-title":"J Neurooncol"},{"key":"1710_CR15","doi-asserted-by":"publisher","first-page":"14002","DOI":"10.3390\/ijms241814002","volume":"24","author":"M Araujo-Castro","year":"2023","unstructured":"Araujo-Castro M, Marazuela M, Puig-Domingo M, Biagetti B (2023) Prolactin and Growth Hormone Signaling and Interlink Focused on the Mammosomatotroph Paradigm: A Comprehensive Review of the Literature. IJMS 24:14002. https:\/\/doi.org\/10.3390\/ijms241814002","journal-title":"IJMS"},{"key":"1710_CR16","doi-asserted-by":"publisher","first-page":"e2178","DOI":"10.1210\/clinem\/dgae126","volume":"109","author":"M Araujo-Castro","year":"2024","unstructured":"Araujo-Castro M, Biagetti B, Men\u00e9ndez Torre E et al (2024) Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases. J Clin Endocrinol Metab 109:e2178\u2013e2187. https:\/\/doi.org\/10.1210\/clinem\/dgae126","journal-title":"J Clin Endocrinol Metab"},{"key":"1710_CR17","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3171\/2022.8.JNS221890","volume":"138","author":"RC Osorio","year":"2023","unstructured":"Osorio RC, Pereira MP, Oh T et al (2023) Correlation between tumor volume and serum prolactin and its effect on surgical outcomes in a cohort of 219 prolactinoma patients. J Neurosurg 138:1669\u20131679. https:\/\/doi.org\/10.3171\/2022.8.JNS221890","journal-title":"J Neurosurg"},{"key":"1710_CR18","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","volume":"33","author":"P Chanson","year":"2019","unstructured":"Chanson P, Maiter D (2019) The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new. Best Pract Res Clin Endocrinol Metab 33:101290. https:\/\/doi.org\/10.1016\/j.beem.2019.101290","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1710_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR et al (2011) Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metabolism 96:273\u2013288. https:\/\/doi.org\/10.1210\/jc.2010-1692","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1710_CR20","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1365-2265.2006.02627.x","volume":"65","author":"N Karavitaki","year":"2006","unstructured":"Karavitaki N, Thanabalasingham G, Shore HCA et al (2006) Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf) 65:524\u2013529. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02627.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1710_CR21","doi-asserted-by":"publisher","first-page":"luaf241","DOI":"10.1210\/jcemcr\/luaf241","volume":"3","author":"MHT Leong","year":"2025","unstructured":"Leong MHT, Ang YLY, Nga VDW et al (2025) Challenges in the Management of Silent Lactotroph Pituitary Adenoma. JCEM Case Rep 3:luaf241. https:\/\/doi.org\/10.1210\/jcemcr\/luaf241","journal-title":"JCEM Case Rep"},{"key":"1710_CR22","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1210\/jc.2018-00688","volume":"104","author":"J Drummond","year":"2019","unstructured":"Drummond J, Roncaroli F, Grossman AB, Korbonits M (2019) Clinical and Pathological Aspects of Silent Pituitary Adenomas. J Clin Endocrinol Metab 104:2473\u20132489. https:\/\/doi.org\/10.1210\/jc.2018-00688","journal-title":"J Clin Endocrinol Metab"},{"key":"1710_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3171\/2018.4.JNS18230","volume":"131","author":"J Rick","year":"2019","unstructured":"Rick J, Jahangiri A, Flanigan PM et al (2019) Growth hormone and prolactin-staining tumors causing acromegaly: a retrospective review of clinical presentations and surgical outcomes. J Neurosurg 131:147\u2013153. https:\/\/doi.org\/10.3171\/2018.4.JNS18230","journal-title":"J Neurosurg"},{"key":"1710_CR24","doi-asserted-by":"publisher","first-page":"e31305","DOI":"10.1371\/journal.pone.0031305","volume":"7","author":"F Roelfsema","year":"2012","unstructured":"Roelfsema F, Pijl H, Keenan DM, Veldhuis JD (2012) Prolactin Secretion in Healthy Adults Is Determined by Gender, Age and Body Mass Index. PLoS ONE 7:e31305. https:\/\/doi.org\/10.1371\/journal.pone.0031305","journal-title":"PLoS ONE"},{"key":"1710_CR25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/biomedicines14010234","volume":"14","author":"M Komisarz-Calik","year":"2026","unstructured":"Komisarz-Calik M, Bogus\u0142awska A, Gamrat-\u017bmuda A et al (2026) The Differences Between Dopamine Agonist-Resistant and -Non-Resistant Prolactinomas: Are There Any Predictors of a Good Response? Biomedicines 14:234. https:\/\/doi.org\/10.3390\/biomedicines14010234","journal-title":"Biomedicines"},{"key":"1710_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12902-020-0543-4","volume":"20","author":"E Vermeulen","year":"2020","unstructured":"Vermeulen E, D\u2019Haens J, Stadnik T et al (2020) Predictors of dopamine agonist resistance in prolactinoma patients. BMC Endocr Disord 20:68. https:\/\/doi.org\/10.1186\/s12902-020-0543-4","journal-title":"BMC Endocr Disord"},{"key":"1710_CR27","doi-asserted-by":"publisher","first-page":"eAO1694","DOI":"10.31744\/einstein_journal\/2025AO1694","volume":"23","author":"SA Galliano","year":"2025","unstructured":"Galliano SA, Stumpf MAM, Queiroz NL et al (2025) A new and useful tool for differentiating prolactinomas from non-functioning pituitary adenomas: a pilot study of the cabergoline disconnection test. Einstein (Sao Paulo) 23:eAO1694. https:\/\/doi.org\/10.31744\/einstein_journal\/2025AO1694","journal-title":"Einstein (Sao Paulo)"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01710-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01710-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01710-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:42:04Z","timestamp":1788457324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01710-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1710"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01710-9","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"126"}}